Rwanda FDA suspends all Relief tablets

The Rwanda Food and Drugs Authority (Rwanda FDA) has suspened the importation, distribution, and use of all RELIEF tablets until further notice. The suspension announced in a public statement released on June 11, the FDA citing that post-marketing surveillance had detected unauthorized medicines branded as "RELIEF" on the Rwandan market. These tablets, available in various dosages, contain a combination of Diclofenac Sodium, Paracetamol, Chlorpheniramine Maleate, and Magnesium Trisilicate. "All importers, distributors, and retail pharmacies are required to immediately cease the distribution

The Rwanda Food and Drugs Authority (Rwanda FDA) has suspened the importation, distribution, and use of all RELIEF tablets until further notice. The suspension announced in a public statement released on June 11, the FDA citing that post-marketing surveillance had detected unauthorized medicines branded as "RELIEF" on the Rwandan market. These tablets, available in various dosages, contain a combination of Diclofenac Sodium, Paracetamol, Chlorpheniramine Maleate, and Magnesium Trisilicate. "All importers, distributors, and retail pharmacies are required to immediately cease the distribution and dispensing of RELIEF tablets and quarantine all existing stock,”FDA stated in the statement. Rwanda FDA strongly advises the public against purchasing or using any RELIEF tablets, until further notice. The authority also reminded public that the importation, distribution, or dispensing of unapproved medicines is illegal and punishable by law.